Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Zaccardi and Kamlesh Khunti.
Connection Strength
10.595
-
Using observational data to prioritise COVID-19 vaccination strategies: opportunity or necessity? Public Health. 2021 08; 197:e20.
Score: 0.928
-
Glucose dysregulation phenotypes - time to improve outcomes. Nat Rev Endocrinol. 2018 11; 14(11):632-633.
Score: 0.793
-
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates. Diabetologia. 2018 07; 61(7):1592-1602.
Score: 0.766
-
Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2018 04; 271:223-231.
Score: 0.757
-
Diabetes: Predicting severe hypoglycaemia - a step forward. Nat Rev Endocrinol. 2017 12; 13(12):692-693.
Score: 0.739
-
Comment on: "Strengths and Limitations of Healthcare Databases in the Evaluation of Hypoglycaemia". Diabetes Obes Metab. 2017 10; 19(10):1495-1496.
Score: 0.726
-
Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England. Diabetes Obes Metab. 2017 10; 19(10):1371-1378.
Score: 0.713
-
Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation. Diabetologia. 2017 06; 60(6):1007-1015.
Score: 0.708
-
Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort. BMC Infect Dis. 2021 Jul 31; 21(1):717.
Score: 0.240
-
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort. Obesity (Silver Spring). 2021 07; 29(7):1223-1230.
Score: 0.236
-
Association of working shifts, inside and outside of healthcare, with severe COVID-19: an observational study. BMC Public Health. 2021 04 22; 21(1):773.
Score: 0.235
-
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021 05; 9(5):293-303.
Score: 0.234
-
Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank. Int J Obes (Lond). 2021 05; 45(5):1155-1159.
Score: 0.233
-
Uses and abuses of real-world data in generating evidence during a pandemic. J R Soc Med. 2021 03; 114(3):109-110.
Score: 0.231
-
The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis. Endocrinol Diabetes Metab. 2020 Aug 14; e00176.
Score: 0.224
-
Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020 10; 22(10):1915-1924.
Score: 0.223
-
COVID-19 cumulative mortality rates for frontline healthcare staff in England. Br J Gen Pract. 2020 Jul; 70(696):327-328.
Score: 0.222
-
Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):965-967.
Score: 0.222
-
Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.). Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):1281.
Score: 0.222
-
Multimorbidity and SARS-CoV-2 infection in UK Biobank. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):775-776.
Score: 0.221
-
Obesity and risk of COVID-19: analysis of UK biobank. Prim Care Diabetes. 2020 10; 14(5):566-567.
Score: 0.221
-
Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis. Acta Diabetol. 2019 Mar; 56(3):331-339.
Score: 0.199
-
Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide study. J Diabetes. 2019 Apr; 11(4):265-272.
Score: 0.197
-
Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2018 04; 20(4):985-997.
Score: 0.187
-
Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study. Eur Heart J. 2017 Nov 14; 38(43):3232-3240.
Score: 0.185
-
Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England. JAMA Pediatr. 2021 09 01; 175(9):928-938.
Score: 0.060
-
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021 08 26; 374:n1931.
Score: 0.060
-
Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec; 5(6):997-1007.
Score: 0.060
-
Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation. Eur J Public Health. 2021 07 13; 31(3):630-634.
Score: 0.060
-
Quantifying the association between ethnicity and COVID-19 mortality: a national cohort study protocol. BMJ Open. 2021 04 07; 11(4):e045286.
Score: 0.059
-
No cases of asymptomatic SARS-CoV-2 infection among healthcare staff in a city under lockdown restrictions: lessons to inform 'Operation Moonshot'. J Public Health (Oxf). 2020 Dec 26.
Score: 0.058
-
Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff. J Public Health (Oxf). 2020 Nov 16.
Score: 0.057
-
Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study. Mayo Clin Proc. 2021 01; 96(1):156-164.
Score: 0.057
-
Body mass index and the risk of COVID-19 across ethnic groups: Analysis of UK Biobank. Diabetes Obes Metab. 2020 10; 22(10):1953-1954.
Score: 0.056
-
20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. 2019 08; 4(8):e406-e420.
Score: 0.052
-
Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational Study. Exp Clin Endocrinol Diabetes. 2021 Jun; 129(6):413-419.
Score: 0.052
-
Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis. Liver Int. 2019 03; 39(3):557-567.
Score: 0.050
-
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol. BMJ Open. 2018 11 08; 8(11):e023206.
Score: 0.050